Curtis R Coughlin1, Gunter H Scharer2, Marisa W Friederich1, Hung-Chun Yu1, Elizabeth A Geiger1, Geralyn Creadon-Swindell1, Abigail E Collins3, Arnaud V Vanlander4, Rudy Van Coster4, Christopher A Powell5, Michael A Swanson1, Michal Minczuk5, Johan L K Van Hove1, Tamim H Shaikh6. 1. Department of Pediatrics, Section of Genetics, University of Colorado School of Medicine, Aurora, Colorado, USA. 2. Department of Pediatrics, Section of Genetics, University of Colorado School of Medicine, Aurora, Colorado, USA Intellectual and Developmental Disabilities Research Center, University of Colorado School of Medicine, Aurora, Colorado, USA Department of Pediatrics, Section of Clinical Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. 3. Department of Pediatrics, Section of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA. 4. Department of Pediatrics, Division of Pediatric Neurology and Metabolism, Ghent University Hospital, Ghent, Belgium. 5. MRC Mitochondrial Biology Unit, Cambridge, UK. 6. Department of Pediatrics, Section of Genetics, University of Colorado School of Medicine, Aurora, Colorado, USA Intellectual and Developmental Disabilities Research Center, University of Colorado School of Medicine, Aurora, Colorado, USA.
Abstract
BACKGROUND: Mitochondrial disease is often suspected in cases of severe epileptic encephalopathy especially when a complex movement disorder, liver involvement and progressive developmental regression are present. Although mutations in either mitochondrial DNA or POLG are often present, other nuclear defects in mitochondrial DNA replication and protein translation have been associated with a severe epileptic encephalopathy. METHODS AND RESULTS: We identified a proband with an epileptic encephalopathy, complex movement disorder and a combined mitochondrial respiratory chain enzyme deficiency. The child presented with neurological regression, complex movement disorder and intractable seizures. A combined deficiency of mitochondrial complexes I, III and IV was noted in liver tissue, along with increased mitochondrial DNA content in skeletal muscle. Incomplete assembly of complex V, using blue native polyacrylamide gel electrophoretic analysis and complex I, using western blotting, suggested a disorder of mitochondrial transcription or translation. Exome sequencing identified compound heterozygous mutations in CARS2, a mitochondrial aminoacyl-tRNA synthetase. Both mutations affect highly conserved amino acids located within the functional ligase domain of the cysteinyl-tRNA synthase. A specific decrease in the amount of charged mt-tRNA(Cys) was detected in patient fibroblasts compared with controls. Retroviral transfection of the wild-type CARS2 into patient skin fibroblasts led to the correction of the incomplete assembly of complex V, providing functional evidence for the role of CARS2 mutations in disease aetiology. CONCLUSIONS: Our findings indicate that mutations in CARS2 result in a mitochondrial translational defect as seen in individuals with mitochondrial epileptic encephalopathy. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND: Mitochondrial disease is often suspected in cases of severe epileptic encephalopathy especially when a complex movement disorder, liver involvement and progressive developmental regression are present. Although mutations in either mitochondrial DNA or POLG are often present, other nuclear defects in mitochondrial DNA replication and protein translation have been associated with a severe epileptic encephalopathy. METHODS AND RESULTS: We identified a proband with an epileptic encephalopathy, complex movement disorder and a combined mitochondrial respiratory chain enzyme deficiency. The child presented with neurological regression, complex movement disorder and intractable seizures. A combined deficiency of mitochondrial complexes I, III and IV was noted in liver tissue, along with increased mitochondrial DNA content in skeletal muscle. Incomplete assembly of complex V, using blue native polyacrylamide gel electrophoretic analysis and complex I, using western blotting, suggested a disorder of mitochondrial transcription or translation. Exome sequencing identified compound heterozygous mutations in CARS2, a mitochondrial aminoacyl-tRNA synthetase. Both mutations affect highly conserved amino acids located within the functional ligase domain of the cysteinyl-tRNA synthase. A specific decrease in the amount of charged mt-tRNA(Cys) was detected in patient fibroblasts compared with controls. Retroviral transfection of the wild-type CARS2 into patient skin fibroblasts led to the correction of the incomplete assembly of complex V, providing functional evidence for the role of CARS2 mutations in disease aetiology. CONCLUSIONS: Our findings indicate that mutations in CARS2 result in a mitochondrial translational defect as seen in individuals with mitochondrial epileptic encephalopathy. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Marisa W Friederich; Alican J Erdogan; Curtis R Coughlin; Mihret T Elos; Hua Jiang; Courtney P O'Rourke; Mark A Lovell; Eric Wartchow; Katherine Gowan; Kathryn C Chatfield; Wallace S Chick; Elaine B Spector; Johan L K Van Hove; Jan Riemer Journal: Hum Mol Genet Date: 2017-02-15 Impact factor: 6.150
Authors: Kaz M Knight; Emily Shelkowitz; Austin A Larson; David M Mirsky; Yue Wang; Ting Chen; Lee-Jun Wong; Marisa W Friederich; Johan L K Van Hove Journal: Mitochondrion Date: 2020-09-12 Impact factor: 4.160
Authors: F-Nora Vögtle; Björn Brändl; Austin Larson; Manuela Pendziwiat; Marisa W Friederich; Susan M White; Alice Basinger; Cansu Kücükköse; Hiltrud Muhle; Johanna A Jähn; Oliver Keminer; Katherine L Helbig; Carolyn F Delto; Lisa Myketin; Dirk Mossmann; Nils Burger; Noriko Miyake; Audrey Burnett; Andreas van Baalen; Mark A Lovell; Naomichi Matsumoto; Maie Walsh; Hung-Chun Yu; Deepali N Shinde; Ulrich Stephani; Johan L K Van Hove; Franz-Josef Müller; Ingo Helbig Journal: Am J Hum Genet Date: 2018-03-22 Impact factor: 11.025
Authors: Marisa W Friederich; Francisco A Perez; Kaz M Knight; Roxanne A Van Hove; Samuel P Yang; Russell P Saneto; Johan L K Van Hove Journal: Mol Genet Metab Date: 2019-12-30 Impact factor: 4.797